Sonic Fund II L.P. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-30 4:11 pm Sale | 2022-12-27 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 463,143 4.600% | -200,000 (-30.16%) | Filing |
| 2021-04-16 3:11 pm Unchanged | 2021-04-15 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 663,143 6.800% | 0 (Unchanged) | Filing |
| 2021-04-09 4:54 pm Purchase | 2021-03-24 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 663,143 6.800% | 50,000 (+8.15%) | Filing |
| 2021-03-18 2:21 pm Purchase | 2021-03-15 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 613,143 6.300% | 91,528 (+17.55%) | Filing |
| 2021-02-16 3:46 pm Purchase | 2020-12-17 | 13G | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 521,615 5.400% | 96,887 (+22.81%) | Filing |
| 2020-08-20 2:21 pm Purchase | 2020-08-18 | 13D | Adverum Biotechnologies, Inc. ADVM | Sonic Fund II L.P. | 424,728 4.400% | 45,172 (+11.90%) | Filing |